Spasticity Clinical Trial
Official title:
Inter-Rater Reliability of a Spasticity Diagnosis Algorithm
Spasticity is a condition that results from damage to the central nervous system and causes painful muscle contractures that drastically affect level of independence, activities of daily living, and quality of life. Although there are well-known and accepted treatments for spasticity, spasticity is often left undertreated; the specific reasons for this observation are unknown. Because there is no blood test or scan that indicates the presence of spasticity, diagnosis is based entirely on physician impression. Therefore, the investigators hypothesize that one reason that spasticity is undertreated is due to the lack of a standardized diagnostic procedure. This study attempts to test the reliability of a diagnostic flowchart that seeks to increase the accuracy of physician diagnosis of spasticity.
Spasticity is defined as a velocity-dependent increase in stretch reflex with muscle
overactivity, and is associated with involuntary limb movements or spasms which can often be
painful. Active function (such as walking, driving, writing, or sexual activity) can be
adversely affected by spasticity. For patients with significant disability requiring a
caregiver, passive function (such as facilitation of bathing, dressing, and undergarment
change) can also become very difficult, especially when spasticity is left untreated.
Finally, persistent involuntary motion or spasms may negatively impact an individual's mood
or self image, making social situations more difficult and sometimes overwhelming.
Spasticity is especially undertreated in vulnerable populations; population surveys in
individuals with intellectual disability and nursing home residents have shown that less
than 20% of affected individuals are treated. There are severe negative consequences of
leaving spasticity untreated, like muscle shortening and tendon and soft tissue
contractures. Once developed, contractures are very difficult to treat and can hinder
personal hygiene and dressing, and well as the ability to sit or lie properly. Bad hygiene
and immobility can lead, in turn, to urinary tract infections, pressure ulcers and skin
breakdown. Furthermore, spasticity can stunt muscle growth and cause abnormal bone growth
and formation, especially in children.
Spasticity is diagnosed based upon a physician's clinical impression; there is currently no
biomarker to facilitate an objective diagnosis. The two instruments most commonly used to
document severity are the Modified Ashworth Scale and Range of Motion Assessment. Both
assessments are based upon a clinician's assessment of muscle tone, but there is no
widely-accepted protocol to determine the presence of spasticity. We therefore hypothesize
one reason spasticity is widely undertreated is the challenge faced by physicians when
attempting to make a diagnosis. In the absence of a biomarker, a more standardized method of
clinical diagnosis is necessary, both for future research and for advocacy efforts. The
treatment of spasticity could increase quality of life by allowing an individual to
participate more independently in activities of daily living, and by making assistance
easier for caregivers.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06150729 -
Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy
|
||
Completed |
NCT02400619 -
Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT
|
Phase 1 | |
Completed |
NCT02261142 -
Efficacy and Cost-effectiveness of Spasticity Treatment With Multifocal TENS
|
N/A | |
Completed |
NCT01945684 -
A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
|
Phase 3 | |
Completed |
NCT01444794 -
Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
|
||
Terminated |
NCT02877836 -
Functional MRI and DTI in the Preoperative Assessment of Dystonia
|
N/A | |
Completed |
NCT02334683 -
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
|
N/A | |
Completed |
NCT02170779 -
Developing and Testing a Comprehensive MS Spasticity Management Program
|
Phase 2 | |
Recruiting |
NCT05674604 -
Cryoneurolysis for Knee and Shoulder Pain in an Inpatient Setting
|
||
Not yet recruiting |
NCT05926596 -
Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
|
N/A | |
Terminated |
NCT01712087 -
Long-term Surveillance of the MedStream Programmable Infusion System
|
||
Completed |
NCT03906305 -
Dry Needling and Bobath Treatment Clinical Effects Focused on Stroke Patients
|
N/A | |
Completed |
NCT03302741 -
Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings
|
Phase 4 | |
Completed |
NCT02291159 -
Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke
|
N/A | |
Completed |
NCT01743651 -
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
|
Phase 3 | |
Completed |
NCT01523210 -
DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle
|
N/A | |
Completed |
NCT02073513 -
Kinesiotaping the Hand in Cerebral Palsy
|
N/A | |
Completed |
NCT00607542 -
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
|
Phase 1/Phase 2 | |
Completed |
NCT00702468 -
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
|
Phase 3 | |
Active, not recruiting |
NCT04815967 -
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
|
Phase 2/Phase 3 |